The Patterns of P53, E-Cadherin, β-Catenin, CXCR4 and Podoplanin Expression in Oral Squamous Cell Carcinoma Suggests a Hybrid Invasion Model: an Immunohistochemical Study on Tissue Microarrays
- PMID: 39776043
- PMCID: PMC11707092
- DOI: 10.1007/s12105-024-01745-z
The Patterns of P53, E-Cadherin, β-Catenin, CXCR4 and Podoplanin Expression in Oral Squamous Cell Carcinoma Suggests a Hybrid Invasion Model: an Immunohistochemical Study on Tissue Microarrays
Abstract
Purpose: Oral squamous cell carcinoma (OSCC) is a significant public health challenge associated with high mortality rates primarily due to its invasive and metastatic behavior. This study aimed to evaluate the expression patterns of five critical biomarkers: β-catenin, E-cadherin, podoplanin (PDPN), CXCR4, and p53 in OSCC tissues and to investigate their correlations with clinicopathologic features and patient outcomes.
Methods: We conducted an immunohistochemical analysis utilizing tissue microarrays (TMAs) from 95 patients diagnosed with primary OSCC. The expression levels of the five biomarkers were quantified using H-scores. Statistical analyses, including Kruskal-Wallis tests, Dunn's post-hoc tests, and correlation analyses, were performed to explore the associations between biomarker expression, clinicopathologic parameters, and overall patient survival.
Results: The study found that loss of E-cadherin and β-catenin expression was significantly associated with increased tumor depth and lymphatic invasion, corroborating their role in the process of epithelial-mesenchymal transition (EMT). High levels of PDPN were noted in both early and late-stage OSCC, indicating its potential involvement in initiating invasive behaviors. Notably, CXCR4 expression exhibited positive correlations with E-cadherin and β-catenin, suggesting a hybrid invasion phenotype incorporating both EMT and collective invasion strategies. Although Cox regression analysis did not reveal significant associations between biomarker expression and overall survival (OS) or disease-specific survival (DSS), factors such as alcohol consumption, tumor size, lymph node involvement, and advanced clinical stage emerged as significant negative predictors of both OS and DSS.
Conclusion: The expression profiles of β-catenin, E-cadherin, PDPN, CXCR4, and p53 in OSCC tissues provide valuable insights into a hybrid model of invasion that integrates mechanisms of EMT with an important rule in the tumor invasion. This nuanced understanding of OSCC progression highlights the potential of PDPN and CXCR4 as novel therapeutic targets, emphasizing the need for further investigation into their roles in OSCC biology and the development of targeted treatments that could improve patient outcomes and survival rates.
Keywords: Epithelial-mesenchymal transition; Oral squamous cell carcinoma; Tissue microarray.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Competing Interests: The authors declare no competing interests.
Similar articles
-
Expression of E-cadherin, Twist, and p53 and their prognostic value in patients with oral squamous cell carcinoma.J Cancer Res Clin Oncol. 2013 Oct;139(10):1735-44. doi: 10.1007/s00432-013-1499-9. Epub 2013 Aug 30. J Cancer Res Clin Oncol. 2013. PMID: 23990016 Free PMC article.
-
Bioinformatics identification and validation of m6A/m1A/m5C/m7G/ac4 C-modified genes in oral squamous cell carcinoma.BMC Cancer. 2025 Jul 1;25(1):1055. doi: 10.1186/s12885-025-14216-7. BMC Cancer. 2025. PMID: 40597017 Free PMC article.
-
Periostin Promotes Invasiveness and Metastasis of Oral Cancer via Epithelial-mesenchymal Transition.Anticancer Res. 2025 Jul;45(7):3099-3115. doi: 10.21873/anticanres.17674. Anticancer Res. 2025. PMID: 40578940
-
Prognostic significance of B-Catenin and E-Cadherin expression in gastric carcinoma.J Immunoassay Immunochem. 2025;46(4):317-330. doi: 10.1080/15321819.2025.2505033. Epub 2025 May 14. J Immunoassay Immunochem. 2025. PMID: 40366977 Review.
-
Management of clinically node-negative early-stage oral cancer: network meta-analysis of randomized clinical trials.Int J Oral Maxillofac Surg. 2024 Mar;53(3):179-190. doi: 10.1016/j.ijom.2023.08.004. Epub 2023 Sep 1. Int J Oral Maxillofac Surg. 2024. PMID: 37661515 Review.
References
-
- Bray F et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229–263. 10.3322/caac.21834 - PubMed
-
- Instituto Nacional De Câncer (2023) Estimativa 2023: incidência de câncer no Brasil. Rio de Janeiro. Accessed 03 Nov 2024. https://www.inca.gov.br/publicacoes/livros/estimativa-2023-incidencia-de...
-
- Gharat SA, Momin M, Bhavsar C (2016) Oral squamous cell carcinoma: current treatment strategies and nanotechnology-based approaches for Prevention and Therapy. Crit Rev Ther Drug Carrier Syst 33(4):363–400. 10.1615/CritRevTherDrugCarrierSyst.2016016272 - PubMed
-
- Gigliotti J, Madathil S, Makhoul N (Sep. 2019) Delays in oral cavity cancer. Int J Oral Maxillofac Surg 48(9):1131–1137. 10.1016/j.ijom.2019.02.015 - PubMed
MeSH terms
Substances
Grants and funding
- 88887.932709/2024-00/Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- 88887.932709/2024-00/Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- 23/11402-4/Fundação de Amparo à Pesquisa do Estado de São Paulo
- 10/51168-0/Fundação de Amparo à Pesquisa do Estado de São Paulo
- 304389/2015-3/Conselho Nacional de Desenvolvimento Científico e Tecnológico
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous